LABORATOIRE ELAIAPHARM

laboratoire-elaiapharm-logo

Laboratoire Elaiapharm S.A., a pharmaceutical contract manufacturing organization, provides pharmaceutical development, manufacturing, and commercial and clinical packaging services. Its development services include feasibility studies, pre-formulation and formulation, process development and validation, galenic development, process optimization, reformulation and life cycle management, development and validation of analytical methods, ICH stabilities, and regulatory support and documentation. T... he company also engages in manufacturing solid dose, liquid, sterile, and non-sterile products, such as tablets, powders, hard capsules, vials, ampoules, bottles, drops, and active pharmaceutical ingredients. In addition, it offers primary and secondary packaging, clinical packaging, late stage customization, labeling, artworks management, and logistics and distribution services; and dossiers development and licensing services.

#Website #More

LABORATOIRE ELAIAPHARM

Social Links:

Industry:
Manufacturing Pharmaceutical

Founded:
1997-01-01

Address:
Sophia Antipolis, Provence-Alpes-Cote D'Azur, France

Country:
France

Website Url:
http://www.lundbeck.com

Total Employee:
11+

Status:
Active

Contact:
+33493954949

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache Amazon Elastic Load Balancing Sticky Session SEO_H1 Adobe Dynamic Tag Management Adobe Experience Manager Cognito Forms


Official Site Inspections

http://www.lundbeck.com

  • Host name: server-99-84-208-27.iad79.r.cloudfront.net
  • IP address: 99.84.208.27
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Laboratoire Elaiapharm"

Organization and ownership - lundbeck.com

Lundbeck's largest shareholder is the Lundbeck Foundation, which owns roughly 70% of the shares in Lundbeck, while the remaining 30% are traded on the stock exchange. Lundbeck is …See details»

This is Lundbeck

We are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization. Our purpose is clear: We are tirelessly …See details»

Packaging, serialization and aggregation - Lundbeck

Lundbeck CDM offers Contract Development & Manufacturing Organization services for Solid dosage forms, with end-to-end services from small scale trial, to clinical batches until commercial manufacturing of your medicines.See details»

Laboratoire Elaiapharm - Crunchbase Company Profile & Funding

Laboratoire Elaiapharm S.A., a pharmaceutical contract manufacturing organization, provides pharmaceutical development, manufacturing, and commercial and clinical packaging services. …See details»

Lundbeck acquires Laboratoire Elaiapharm - 2009-10-07

Oct 7, 2009 · Acquiring Organization: Lundbeck Lundbeck is a pharmaceutical company that develops products to treat people with psychiatric and neurological disorders. Announced Date …See details»

Laboratoire Elaiapharm Lundbeck - LinkedIn

Laboratoire Elaiapharm Lundbeck | 257 followers on LinkedIn. ... Grégory BRATULIC CHARGÉ DES MOYENS GENERAUX / GESTION DE PROJETS / TECHNICIEN METHODESSee details»

Elaiapharm, un site de production aguerri à la sous-traitance

Filiale du groupe pharmaceutique Lundbeck depuis 2009, le site de production Elaiapharm, dans les Alpes-Maritimes, réalise 50 % de son activité auprès de sociétés tiers. Une stratégie ...See details»

Lundbeck - Crunchbase Company Profile & Funding

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is …See details»

About Us - lundbeck.com

Lundbeck is a global pharmaceutical company specialized in brain diseases. We focus on neuroscience research, development, manufacturing, and commercialization.See details»

H Lundbeck eschews outsourcing and buys Elaiapharm

Oct 20, 2009 · CNS focused drugmaker H Lundbeck says its acquisition of French CMO Elaiapharm represents a cheaper option than third-party manufacturing.See details»

Lourdes Pla – General Manager, Lundbeck France

May 12, 2018 · Lundbeck first established a presence in France back in 1992 and subsequently, in 2009, acquired a pharmaceutical production unit, Elaiapharm, located in the Sophia-Antipolis technopole of the Alpes-Maritimes.See details»

Comment Elaiapharm à Sophia a réussi son intégration au groupe ...

Nov 29, 2019 · A Sophia, le site de Lundbeck Pharmaceuticals France, anciennement Elaiapharm, fête les dix ans de son intégration dans le groupe pharmaceutique danois …See details»

Comment Elaiapharm Lundbeck est devenu à Sophia Antipolis un …

Jun 30, 2022 · Le site de production français d’Elaiapharm est un élément stratégique pour le groupe Lundbeck. "Les investissements récents le prouvent", souligne son responsable …See details»

This is Lundbeck

Lundbeck is a global pharmaceutical company specialized in developing innovative treatments for brain diseases. For more than 70 years, millions of people have been treated with our …See details»

Elaiapharm investit pour aider 7 millions de malades - Le Journal …

Dec 22, 2020 · Racheté en 2009 par le groupe danois Lundbeck, ce site produit des médicaments destinés aux maladies du système nerveux central, principalement la schizophrénie, …See details»

Advicenne Signs Manufacturing Agreement with Elaiapharm …

Sep 12, 2019 · French CDMO to produce Advicenne’s lead candidate ADV7103 through long-term manufacturing supply agreementSee details»

Lundbeck, l'entreprise danoise qui monte à Sophia Antipolis

Dec 13, 2019 · En France, Lundbeck fait de la recherche clinique depuis 50 ans, a créé une filiale commerciale il y a 30 ans puis acquis Elaiapharm, dont le laboratoire était l'un des plus gros …See details»

Our commitment - Lundbeck

Lundbeck employs a multifaceted approach to treating brain diseases. We are engaged in the medical community, with families, and patients themselves.See details»

Advicenne secures production of ADV7103 through long

Sep 4, 2019 · Based in Sophia Antipolis, France, Elaiapharm, a wholly owned subsidiary of the renowned H. Lundbeck A/S, provides contract development and manufacturing services to the …See details»

Pharmaceutical Development - Lundbeck

We offer high flexibility, technical expertise and experience to develop and produce your oral solid drug products. Your development projects are eligible for the Research Tax Credit (CIR) up to …See details»